Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 646 AL 660

[Gaucher disease: A review]

Nguyen Y, Stirnemann J, Belmatoug N.

Rev Med Interne. 2019 May;40(5):313-322. doi: 10.1016/j.revmed.2018.11.012. Epub 2019 Jan 11.

Differentiation of human mesenchymal stem cells (MSC) to dopaminergic neurons: A comparison between Wharton's Jelly and olfactory mucosa as sources of MSCs

Alizadeh R, Bagher Z, Kamrava SK, Falah M, Ghasemi Hamidabadi H, Eskandarian Boroujeni M, Mohammadi F, Khodaverdi S, Zare-Sadeghi A, Olya A, Komeili A.

J Chem Neuroanat. 2019 Mar;96:126-133. doi: 10.1016/j.jchemneu.2019.01.003. Epub 2019 Jan 10.

Unknown fates of (brain) oxidation or UFO: Close encounters with neuronal senescence

Walton CC, Andersen JK.

Free Radic Biol Med. 2019 Apr;134:695-701. doi: 10.1016/j.freeradbiomed.2019.01.012. Epub 2019 Jan 9.

Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footing

Meyer GM, Spay C, Laurencin C, Ballanger B, Sescousse G, Boulinguez P.

Neurosci Biobehav Rev. 2019 Mar;98:164-176. doi: 10.1016/j.neubiorev.2019.01.008. Epub 2019 Jan 9.

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial

Athauda D, Gulyani S, Karnati HK, Li Y, Tweedie D, Mustapic M, Chawla S, Chowdhury K, Skene SS, Greig NH, Kapogiannis D, Foltynie T.

JAMA Neurol. 2019 Apr 1;76(4):420-429. doi: 10.1001/jamaneurol.2018.4304.

Approaching drug-induced parkinsonism from a neurohospitalist perspective

Margolesky J.

Expert Rev Neurother. 2019 Feb;19(2):93-95. doi: 10.1080/14737175.2019.1569515. Epub 2019 Jan 16.

Physiotherapy Versus Physiotherapy Plus Cognitive Training on Cognition and Quality of Life in Parkinson Disease: Randomized Clinical Trial

Barboza NM, Terra MB, Bueno MEB, Christofoletti G, Smaili SM.

Am J Phys Med Rehabil. 2019 Jun;98(6):460-468. doi: 10.1097/PHM.0000000000001128.

Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease

Geibl FF, Henrich MT, Oertel WH.

J Neural Transm (Vienna). 2019 Apr;126(4):377-396. doi: 10.1007/s00702-019-01970-9. Epub 2019 Jan 14.

Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model

Birla H, Rai SN, Singh SS, Zahra W, Rawat A, Tiwari N, Singh RK, Pathak A, Singh SP.

Neuromolecular Med. 2019 Mar;21(1):42-53. doi: 10.1007/s12017-018-08521-7. Epub 2019 Jan 14.

COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations

Wang YC, Zou YB, Xiao J, Pan CD, Jiang SD, Zheng ZJ, Yan ZR, Tang KY, Tan LM, Tang MS.

Neurol Res. 2019 Apr;41(4):319-325. doi: 10.1080/01616412.2018.1564183. Epub 2019 Jan 15.

Differential Expression of Striatal ΔFosB mRNA and FosB mRNA After Different Levodopa Treatment Regimens in a Rat Model of Parkinson's Disease

Palafox-Sanchez V, Sosti V, Ramirez-García G, Kulisevsky J, Aguilera J, Limón ID.

Neurotox Res. 2019 Apr;35(3):563-574. doi: 10.1007/s12640-018-9993-0. Epub 2019 Jan 15.

Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease

Ramírez-Gómez CC, Zúñiga-Ramírez C, Contartese ML, Montilla V, Gramajo J, Micheli F.

Clin Neuropharmacol. 2019 Jan/Feb;42(1):14-16. doi: 10.1097/WNF.0000000000000316.

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders

Yilmaz A, Fuchs D, Price RW, Spudich S, Blennow K, Zetterberg H, Gisslén M.

Curr HIV/AIDS Rep. 2019 Feb;16(1):76-81. doi: 10.1007/s11904-019-00420-1.

Large Hemorrhagic Cerebral Venous Infarction due to Deep Brain Stimulation Leads Placement. Report of 2 Cases

Sobstyl M, Brzuszkiewicz-Kuźmicka G, Aleksandrowicz M, Pasterski T.

Turk Neurosurg. 2019;29(4):611-614. doi: 10.5137/1019-5149.JTN.22281-17.3.

Mitohormesis and autophagic balance in Parkinson disease

Juarez-Flores DL, Gonzalez-Casacuberta I, Garrabou G.

Aging (Albany NY). 2019 Jan 16;11(2):301-302. doi: 10.18632/aging.101779.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias